These results suggest that expression of specific IGH variable regions may cooperate with EBV infection to induce lymphomas in the cord blood-humanized mouse model, particularly since specific variable IGH gene usage (and specific CDR3 sequences) support the growth of human DLBCLs and CLL tumors by enhancing BCR signaling [82–85]. This evidence concerns the gene BCR and lymphoma.